Pneumoconiosis-associated death rates among US coal workers examined from 2020 to 2023

A report examined pneumoconiosis-associated death rates among coal workers in the United States from 2020 to 2023. The study type was not specified as a clinical trial, and key methodological details, including the sample size, were not reported. No specific intervention, exposure, or comparator was described for analysis.

The main outcome was death rates associated with pneumoconiosis. The report did not provide the specific death rates, absolute numbers, effect sizes, p-values, confidence intervals, or the direction of any observed trend. Safety and tolerability data, including adverse events, were also not reported.

Key limitations include the unspecified study design and the absence of reported quantitative results and methodological details. The funding sources and potential conflicts of interest were not disclosed. The practice relevance of this report is unclear due to the lack of specific, actionable data on mortality trends or risk factors.